Search

everythinglearnresearchcommunity

for

Search:↓

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

Later line chemotherapy causes severe side effects, impacting quality of life, but patients continue treatment to extend life and stay connected with loved ones.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Abrocitinib may effectively treat stubborn alopecia universalis.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

EGFR inhibitors often cause skin issues like acne and dryness, which can be managed with specific treatments.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.